Page 40 - Lipids News Today

Researchers summarized studies on the association between high-density lipoprotein cholesterol and different types of cancer

Alzheimer's disease is traditionally regarded as neurodegenerative disease, an illness that results in progressive neuronal damage due to protein accumulation.

A national database analysis finds that disparities in primary-prevention statin use persist despite 10-year atherosclerotic cardiovascular disease risk.

Adding time-restricted eating to calorie restriction does not provide added benefits in adults with obesity and nonalcoholic fatty liver disease.

Amgens battle with Sanofi and Regeneron at the Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape US patent law and competition among companies that make antibody medicines.

Amgen sought to convince the US Supreme Court on Monday to revive patents on its cholesterol-lowering drug Repatha, while rival Sanofi urged the justices not to stifle competition for therapies to address a common health risk.

Researchers evaluate the effects of BMI on physical activity-induced intestinal microbiome compositional alterations among middle-aged adult individuals.

In a recent study published in the journal Nutrients, researchers in Italy suggest there is evidence that dietary factors may directly affect the immune system and play a role in chronic systemic inflammation.

Professor Itaru Hamachi, Lecturer Tomonori Tamura, and Assistant Professor Masaki Tsuchiya of Kyoto University have developed a new technology called O-ClickFC (Organelle-selective click labeling with flow cytometry), which can, at a very high speed, analyze the metabolic state of lipids in cells.

Bunge Loders Croklaan – a global producer and supplier of plant-based lipids – is bringing its novel NuliGo molecule to the US market to support muscle health in the trending sports nutrition and active aging categories.